Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
14960 | 739 | 53.2 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
578 | 3 | CHEMOKINES//CXCR4//MACROPHAGE MIGRATION INHIBITORY FACTOR | 16225 |
546 | 2 | CHEMOKINES//CXCR4//CHEMOKINE RECEPTOR | 14674 |
14960 | 1 | CHEMOKINES//CHEMOKINE RECEPTOR//EXPT CLIN NEUROL | 739 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CHEMOKINES | authKW | 332164 | 38% | 3% | 281 |
2 | CHEMOKINE RECEPTOR | authKW | 167108 | 11% | 5% | 82 |
3 | EXPT CLIN NEUROL | address | 123955 | 0% | 100% | 3 |
4 | CCL2 | authKW | 116320 | 5% | 8% | 37 |
5 | IMMUNOBIOL ROBERT H LURIE CANC | address | 92965 | 0% | 75% | 3 |
6 | GPR75 | authKW | 82637 | 0% | 100% | 2 |
7 | MS CLIN | address | 77565 | 2% | 14% | 13 |
8 | MELLEN MULTIPLE SCLEROSIS TREATMENT | address | 73930 | 2% | 10% | 18 |
9 | JOURNAL OF NEUROIMMUNOLOGY | journal | 69104 | 14% | 2% | 106 |
10 | CXCR3 | authKW | 63647 | 3% | 7% | 22 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 6936 | 56% | 0% | 413 |
2 | Immunology | 4419 | 37% | 0% | 277 |
3 | Clinical Neurology | 573 | 13% | 0% | 99 |
4 | Pathology | 333 | 7% | 0% | 49 |
5 | Cell Biology | 142 | 9% | 0% | 67 |
6 | Medicine, Research & Experimental | 67 | 5% | 0% | 35 |
7 | Virology | 46 | 2% | 0% | 18 |
8 | Biochemistry & Molecular Biology | 29 | 10% | 0% | 75 |
9 | Hematology | 27 | 3% | 0% | 20 |
10 | Pharmacology & Pharmacy | 23 | 6% | 0% | 45 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPT CLIN NEUROL | 123955 | 0% | 100% | 3 |
2 | IMMUNOBIOL ROBERT H LURIE CANC | 92965 | 0% | 75% | 3 |
3 | MS CLIN | 77565 | 2% | 14% | 13 |
4 | MELLEN MULTIPLE SCLEROSIS TREATMENT | 73930 | 2% | 10% | 18 |
5 | BLOOD BRAIN BARRIER | 63550 | 1% | 15% | 10 |
6 | PROPEDEUT NEUROL | 61975 | 0% | 50% | 3 |
7 | GENET DESERT | 55090 | 0% | 67% | 2 |
8 | NEUROLALZHEIMERS UNIT | 55090 | 0% | 67% | 2 |
9 | BIOTHER Y DIS | 41318 | 0% | 100% | 1 |
10 | BLOOD BRAIN BARRIER CELL BIOL | 41318 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NEUROIMMUNOLOGY | 69104 | 14% | 2% | 106 |
2 | JOURNAL OF NEUROINFLAMMATION | 9845 | 3% | 1% | 20 |
3 | JOURNAL OF NEUROVIROLOGY | 6235 | 2% | 1% | 15 |
4 | GLIA | 5408 | 3% | 1% | 22 |
5 | MULTIPLE SCLEROSIS JOURNAL | 2117 | 1% | 0% | 11 |
6 | MULTIPLE SCLEROSIS | 1177 | 1% | 1% | 4 |
7 | BRAIN BEHAVIOR AND IMMUNITY | 1070 | 1% | 0% | 8 |
8 | JOURNAL OF IMMUNOLOGY | 1064 | 5% | 0% | 38 |
9 | JOURNAL OF NEUROSCIENCE RESEARCH | 776 | 2% | 0% | 13 |
10 | JOURNAL OF NEUROCHEMISTRY | 763 | 3% | 0% | 20 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CHEMOKINES | 332164 | 38% | 3% | 281 | Search CHEMOKINES | Search CHEMOKINES |
2 | CHEMOKINE RECEPTOR | 167108 | 11% | 5% | 82 | Search CHEMOKINE+RECEPTOR | Search CHEMOKINE+RECEPTOR |
3 | CCL2 | 116320 | 5% | 8% | 37 | Search CCL2 | Search CCL2 |
4 | GPR75 | 82637 | 0% | 100% | 2 | Search GPR75 | Search GPR75 |
5 | CXCR3 | 63647 | 3% | 7% | 22 | Search CXCR3 | Search CXCR3 |
6 | CC CHEMOKINE RECEPTOR 2 CCR2 | 55090 | 0% | 67% | 2 | Search CC+CHEMOKINE+RECEPTOR+2+CCR2 | Search CC+CHEMOKINE+RECEPTOR+2+CCR2 |
7 | DT390 | 55090 | 0% | 67% | 2 | Search DT390 | Search DT390 |
8 | JE MCP 1 | 55090 | 0% | 67% | 2 | Search JE+MCP+1 | Search JE+MCP+1 |
9 | CCR5 DELTA 32 POLYMORPHISM | 46480 | 0% | 38% | 3 | Search CCR5+DELTA+32+POLYMORPHISM | Search CCR5+DELTA+32+POLYMORPHISM |
10 | MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA | 46272 | 1% | 10% | 11 | Search MACROPHAGE+INFLAMMATORY+PROTEIN+1+ALPHA | Search MACROPHAGE+INFLAMMATORY+PROTEIN+1+ALPHA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SZCZUCINSKI, A , LOSY, J , (2007) CHEMOKINES AND CHEMOKINE RECEPTORS IN MULTIPLE SCLEROSIS. POTENTIAL TARGETS FOR NEW THERAPIES.ACTA NEUROLOGICA SCANDINAVICA. VOL. 115. ISSUE 3. P. 137-146 | 65 | 64% | 97 |
2 | SEMPLE, BD , KOSSMANN, T , MORGANTI-KOSSMANN, MC , (2010) ROLE OF CHEMOKINES IN CNS HEALTH AND PATHOLOGY: A FOCUS ON THE CCL2/CCR2 AND CXCL8/CXCR2 NETWORKS.JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. VOL. 30. ISSUE 3. P. 459-473 | 61 | 47% | 118 |
3 | AMBROSINI, E , ALOISI, F , (2004) CHEMOKINES AND GLIAL CELLS: A COMPLEX NETWORK IN THE CENTRAL NERVOUS SYSTEM.NEUROCHEMICAL RESEARCH. VOL. 29. ISSUE 5. P. 1017-1038 | 92 | 40% | 127 |
4 | BANISOR, I , LEIST, TP , KALMAN, B , (2005) INVOLVEMENT OF BETA-CHEMOKINES IN THE DEVELOPMENT OF INFLAMMATORY DEMYELINATION.JOURNAL OF NEUROINFLAMMATION. VOL. 2. ISSUE . P. - | 49 | 73% | 24 |
5 | CARTIER, L , HARTLEY, O , DUBOIS-DAUPHIN, M , KRAUSE, KH , (2005) CHEMOKINE RECEPTORS IN THE CENTRAL NERVOUS SYSTEM: ROLE IN BRAIN INFLAMMATION AND NEURODEGENERATIVE DISEASES.BRAIN RESEARCH REVIEWS. VOL. 48. ISSUE 1. P. 16-42 | 80 | 31% | 261 |
6 | BIBER, K , DE JONG, EK , VAN WEERING, HRJ , BODDEKE, HWGM , (2006) CHEMOKINES AND THEIR RECEPTORS IN CENTRAL NERVOUS SYSTEM DISEASE.CURRENT DRUG TARGETS. VOL. 7. ISSUE 1. P. 29-46 | 81 | 36% | 30 |
7 | MAHAD, DJ , RANSOHOFF, RM , (2003) THE ROLE OF MCP-1 (CCL2) AND CCR2 IN MULTIPLE SCLEROSIS AND EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE).SEMINARS IN IMMUNOLOGY. VOL. 15. ISSUE 1. P. 23-32 | 43 | 51% | 226 |
8 | FIL, D , BORYSIEWICZ, E , KONAT, GW , (2011) A BROAD UPREGULATION OF CEREBRAL CHEMOKINE GENES BY PERIPHERALLY-GENERATED INFLAMMATORY MEDIATORS.METABOLIC BRAIN DISEASE. VOL. 26. ISSUE 1. P. 49-59 | 43 | 46% | 11 |
9 | LOUBOUTIN, JP , STRAYER, DS , (2013) RELATIONSHIP BETWEEN THE CHEMOKINE RECEPTOR CCR5 AND MICROGLIA IN NEUROLOGICAL DISORDERS: CONSEQUENCES OF TARGETING CCR5 ON NEUROINFLAMMATION, NEURONAL DEATH AND REGENERATION IN A MODEL OF EPILEPSY.CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. VOL. 12. ISSUE 6. P. 815-829 | 46 | 37% | 12 |
10 | CONDUCTIER, G , BLONDEAU, N , GUYON, A , NAHON, JL , ROVERE, C , (2010) THE ROLE OF MONOCYTE CHEMOATTRACTANT PROTEIN MCP1/CCL2 IN NEUROINFLAMMATORY DISEASES.JOURNAL OF NEUROIMMUNOLOGY. VOL. 224. ISSUE 1-2. P. 93-100 | 38 | 37% | 140 |
Classes with closest relation at Level 1 |